🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A single center, prospective cohort, open-label study of rabies post exposu...
Status
Completed
Location
Faculty of Medicine, Siriraj Hospital, Mahidol University
Start Date
2015-03
Trial ID
NCT03093545
Treatments Being Tested
This is a Phase 2b, double blinded, randomized study of SYN023 compared to ...
Status
Completed
Location
University of Florida
Start Date
2019-09-03
Trial ID
NCT03961555
Treatments Being Tested
No study was conducted to evaluate the rabies neutralizing antibody titers ...
Status
Unknown
Location
Queen Saovabha Memorial Institute, Thai Red Cross Society
Start Date
2018-04-30
Trial ID
NCT03524417
Treatments Being Tested
A prospective, randomized, blinded, parallel-group, non-inferiority, phase ...
Status
Completed
Location
Prism Research
Start Date
2017-12-08
Trial ID
NCT03264157
This study will evaluate the immune response to rabies vaccination persons ...
Status
Completed
Location
Washington University School of Medicine Infectious Disease Clinical Trials Unit.
Start Date
2023-10-19
Trial ID
NCT07399951
The goal of this clinical trial is to compare the efficacy and safety of GR...
Status
Completed
Location
Center for Disease Control and Prevention (CDC)
Start Date
2022-10-21
Trial ID
NCT05846568
Treatments Being Tested
Rabies immune globulin is a product that is lifesaving to unvaccinated indi...
Status
Completed
Location
CSL Donor Plasma Center
Start Date
2009-01
Trial ID
NCT01063140
Treatments Being Tested
This is single site, randomized, blinded comparison of the immunogenicity, ...
Status
Completed
Location
inVentiv Clinical Research Facility, 1951 NW 7th Ave. Suit 450
Start Date
2016-08
Trial ID
NCT02956746
Treatments Being Tested
A comparative,randomized (1:1)study to evaluate the safety and immunogenici...
Status
Completed
Location
Suda Sibunruang
Start Date
2010-06
Trial ID
NCT01137045
Treatments Being Tested
The purpose of this study is to: 1. Evaluate the safety and tolerability of...
Status
Completed
Location
Prism Research Inc
Start Date
2013-04
Trial ID
NCT02040090
Treatments Being Tested